{"id":"W3159707144","doi":"10.1093/rheumatology/keab247.188","title":"P193 Clinical features of patients with active ankylosing spondylitis who did not respond to adalimumab but responded to ixekizumab: a post-hoc analysis","year":2021,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ixekizumab; Medicine; Ankylosing spondylitis; Adalimumab; Placebo; Post-hoc analysis; BASDAI; Post hoc; Internal medicine; Physical therapy; Tumor necrosis factor alpha; Secukinumab; Pathology; Disease; Alternative medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002312752,0.0009376004,0.002302673,0.0004025447,0.0004555011,0.0008784357,0.0008072924,0.0008856484,0.0060577],"category_scores_gemma":[0.002818695,0.0003723875,0.003898041,0.0003440434,0.0006013446,0.0009889973,0.0005493517,0.001501881,0.0004495807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005904413,"about_ca_system_score_gemma":0.0008281072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006843533,"about_ca_topic_score_gemma":0.0007574672,"domain_scores_codex":[0.9977491,0.001007952,0.000150911,0.0005559189,0.0002292293,0.0003068228],"domain_scores_gemma":[0.9974215,0.001493569,0.000306494,0.0001992771,0.0001937576,0.000385298],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8465099,0.003335769,0.1254714,0.0003690557,0.006998617,0.0002703605,0.0001029781,0.001040114,0.004306674,0.0001203691,0.001455379,0.01001937],"study_design_scores_gemma":[0.1346478,0.2091302,0.6186731,0.00008763245,0.01248824,0.0005925318,0.0005326918,0.01405027,0.004715941,0.0007083764,0.004211321,0.0001620366],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974509,0.0004161651,0.0003001623,0.00006534558,0.00009183208,0.0003219424,0.000711106,0.000009418952,0.0006331907],"genre_scores_gemma":[0.9971992,0.00007346421,0.0002589311,0.00007994599,0.00008939482,0.0004767883,0.001051688,0.000006841126,0.0007637737],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0060577,"threshold_uncertainty_score":0.02026504,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01715853398465701,"score_gpt":0.3096518584205369,"score_spread":0.2924933244358799,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}